04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
• Amendments to the New York State Human Rights Law (NYSHRL) lower the bar for employees and indivi...
Read More >
Paycheck Protection Plan (PPP) loans are Small Business Administration (SBA) Section 7(a) loans. Con...
Read More >
2018’s landmark decision Akorn, Inc. v. Fresenius Kabi AG marked the first time that the Chancery C...
Read More >
Environmental Groups Accuse Multiple Mining Sites of Violating Federal Regulations - "Allegations o...
Read More >
On January 3, 2020, Puerto Rico Governor Wanda Vázquez signed Law No. 9-2020 (“Act 9” or “the Act...
Read More >
As the cannabis industry has rapidly progressed over the years, states such as New York, New Jersey ...
Read More >